Gavi, the Vaccine Alliance, will purchase 500,000 doses of MVA-BN, the Bavarian Nordic Mpox vaccine, as part of an international effort to combat the outbreak of Mpox in certain parts of Africa.
The purchase is being facilitated by Gavi's First Response Fund, a financial mechanism designed to provide rapid funding for the procurement of vaccines during public health emergencies.
